Since the inception of the Comprehensive Sickle Cell Center comprehensive care has been given to adults with clinically significant sickle hemoglobinopathies. The adult patients are assigned to each of three staff physicians who function as a group practice and provide continuity of care . They are assisted by a nurse in the Hematology/Oncology Division and a social worker designated for the Sickle Cell Center. They rotate being attending physician each month for in-patient care. During that month that they are attending physicians for any sickle cell patients that are hospitalized and are consulted by physicians in the Emergency Department when Center patients present. A book in the Emergency Department contains pertinent unique needs for each Center patient as well as recommendations for pain relief. The social worker and research nurse assists in recruiting patients, providing logistical support, and collecting data for research projects in the Project. In addition, a data base is maintained to provide clinical information to investigators. New initiatives are to participate with the Pediatric Clinical Core in a formal transition program whereby adolescent patients are gradually introduced to the adult team through joint pediatric/internal medicine sickle cell clinics. A formal education program will assure that the patients have mastered the cognitive aspects of their disease and will guide them in interacting effectively with the adult care providers. It will also assist them in clarifying lifestyle issues in order to help them lead fulfilled lives.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL058421-03
Application #
6325983
Study Section
Project Start
2000-04-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$192,198
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Crosby, Lori E; Modi, Avani C; Lemanek, Kathleen L et al. (2009) Perceived barriers to clinic appointments for adolescents with sickle cell disease. J Pediatr Hematol Oncol 31:571-6
Crable, Scott C; Hammond, Suzan M; Papes, Richard et al. (2005) Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells. Exp Hematol 33:624-31
Zhou, Guo-Ping; Wong, Clara; Su, Robert et al. (2004) Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element. Blood 103:4302-9
Yasin, Zahida; Witting, Scott; Palascak, Mary B et al. (2003) Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 102:365-70
Merciris, P; Claussen, W J; Joiner, C H et al. (2003) Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells. Pflugers Arch 446:232-8
Holtzclaw, J David; Jiang, Maorong; Yasin, Zahida et al. (2002) Rehydration of high-density sickle erythrocytes in vitro. Blood 100:3017-25
Joiner, C H; Jiang, M; Claussen, W J et al. (2001) Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells. Blood 97:3976-83
Joiner, C H; Franco, R S (2001) The activation of KCL cotransport by deoxygenation and its role in sickle cell dehydration. Blood Cells Mol Dis 27:158-64
Franco, R S; Yasin, Z; Lohmann, J M et al. (2000) The survival characteristics of dense sickle cells. Blood 96:3610-7